[HTML] mdpi.com

[HTML][HTML] Neutrophil-to-lymphocyte ratio as a biomarker predicting overall survival after chemoembolization for intermediate-stage hepatocellular carcinoma

HH Chu, JH Kim, JH Shim, DI Gwon, HK Ko, JH Shin… - Cancers, 2021 - mdpi.com
Simple Summary Baseline neutrophil-to-lymphocyte ratio≥ 3 was a robust independent
predictor of overall survival after chemoembolization for intermediate-stage hepatocellular …
被引用次数：23 相关文章
[HTML] nih.gov

[HTML][HTML] Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma

HH Chu, JH Kim, JH Shim, DI Gwon, HK Ko, JH Shin… - Cancers, 2021 - ncbi.nlm.nih.gov
The clinical impact of neutrophil-to-lymphocyte ratio (NLR) in predicting outcomes in
hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization …

Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma

HH Chu, JH Kim, JH Shim, DI Gwon, HK Ko… - …, 2021 - pubmed.ncbi.nlm.nih.gov
The clinical impact of neutrophil-to-lymphocyte ratio (NLR) in predicting outcomes in
hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization …

Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma.

HH Chu, JH Kim, JH Shim, DI Gwon, HK Ko… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Baseline neutrophil-to-lymphocyte ratio≥ 3 was a robust
independent predictor of overall survival after chemoembolization for intermediate-stage …

Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma

HH Chu, JH Kim, JH Shim, DI Gwon, HK Ko… - …, 2021 - search.proquest.com
The clinical impact of neutrophil-to-lymphocyte ratio (NLR) in predicting outcomes in
hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization …

Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma.

HH Chu, JH Kim, JH Shim, DI Gwon, HK Ko, JH Shin… - Cancers, 2021 - europepmc.org
The clinical impact of neutrophil-to-lymphocyte ratio (NLR) in predicting outcomes in
hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization …